@article{TCR20388,
author = {Moe Tsuda and Masakazu Toi},
title = {Duloxetine for AI-associated joint pain in breast cancer patients},
journal = {Translational Cancer Research},
volume = {7},
number = {Suppl 4},
year = {2018},
keywords = {},
abstract = {Aromatase inhibitors (AIs) are the standard of care for treatment of both early and advanced hormone-sensitive breast cancer in postmenopausal women. Although AIs have been considered to be well-tolerated, only 50 % of patients can complete the full course of the treatment, at the optimal schedule (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/20388}
}